Semaglutide Reconstitution: What the Term Means and Why It Doesn't Apply to Licensed UK Medicines

What does reconstitution actually mean in medicine?

Reconstitution is a standard pharmaceutical step for certain injectable medicines supplied as a freeze-dried or lyophilised powder. A clinician or pharmacist adds a specific volume of sterile liquid (called a reconstitution solution or diluent) to the powder vial, swirls or inverts it until the powder dissolves, then draws the resulting solution into a syringe. The process demands precision: the wrong diluent, the wrong volume, or poor aseptic technique can alter the concentration, introduce contamination, or render the medicine ineffective. You may come across a guide to reconstituting semaglutide online, or even a supposed semaglutide reconstitution chart, but it is worth pausing before trusting either source. These resources are not describing the use of a UK-licensed medicine.

Reconstitution is genuinely appropriate for some medicines, certain antibiotics for intravenous use, for example, or some biologics dispensed in hospital settings. The procedure is tightly controlled there because trained staff manage it under aseptic conditions. Applied to a peptide at home, the risks are multiplied: concentration errors, bacterial contamination and dosing uncertainty are all real possibilities.

The detail that a semaglutide reconstitution calculator even exists as a search term tells you something about how widespread unlicensed semaglutide content has become. None of it reflects how MHRA-authorised treatment works in the UK.

How does licensed semaglutide in the UK actually work?

Wegovy, approved by the MHRA for weight management, is dispensed as a pre-filled, pre-set injection pen. The solution is already prepared by the manufacturer, Novo Nordisk, to a precise concentration under pharmaceutical-grade conditions. You click the pen, hold it to the skin and press the button. There is no vial, no syringe to fill, no reconstitution step and no measuring involved. The Wegovy injection page covers the full licensed product in detail, including dose titration and how the prescribing process works at a regulated UK pharmacy.

The Wegovy tablet, approved by the MHRA on 11 June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management, is taken once daily on an empty stomach with a small amount of plain water. No injection, no preparation, simply a tablet swallowed whole before eating or drinking anything else. The NHS page on semaglutide provides patient-level information on both formulations.

For anyone curious about the body's handling of semaglutide once it is absorbed, our clinical team has covered how semaglutide is metabolised, which is a different question entirely from preparation.

So what is the semaglutide that requires reconstitution?

Compounded semaglutide (sometimes sold as a research peptide, a grey-market injectable, or simply labelled "semaglutide powder") does require mixing before use. It is not licensed by the MHRA for human weight management in the UK. The MHRA has issued repeated public warnings about counterfeit and unlicensed weight-loss injectables: in one enforcement operation, approximately 20 million doses of illegally traded weight-loss medicines with a street value of around £45 million were seized, and a site producing counterfeit tirzepatide pens was found in Northampton in October 2025. Fake and unlicensed products have been found to contain incorrect or harmful substances.

If you found instructions for mixing semaglutide with a reconstitution solution, or a specific protocol for reconstituting a 2mg vial, that content is describing the use of an unlicensed product. The MHRA strongly advises sourcing any prescription weight-loss medicine only through a pharmacy you can verify on the GPhC register, you can check any online pharmacy directly at pharmacyregulation.org. Selling these medicines without a valid prescription is illegal; supplying them as unlicensed compounded peptides sidesteps the safety checks that licensed medicines must pass.

A quick habit worth building: before buying from any online provider, search the pharmacy's name on the GPhC register. It takes under a minute and tells you immediately whether you are dealing with a legitimate, regulated dispensary.

What should you do if you want licensed semaglutide treatment in the UK?

The route to licensed semaglutide for weight management in the UK is a prescription, issued after a proper clinical assessment by a registered prescriber. Private online pharmacies registered with the GPhC can provide this without a GP referral or a waiting list, provided you meet the eligibility criteria. The licensed threshold is a BMI of 30 or above, or 27 or above alongside a weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol; a prescriber reviews the full picture, not the number alone.

You can read about how our clinical team approaches assessments on the clinical team profile page, and if you want to compare semaglutide against other licensed weight-loss options, the weight-loss treatment overview sets out the landscape clearly. For context on what private treatment costs, the Wegovy cost page explains what a legitimate price includes. Treatment is a prescription medicine; cost should never be the primary filter, but transparency matters. NICE's appraisal of semaglutide for weight management (NICE TA875) sets out the clinical evidence base and NHS eligibility criteria, which differ from the private route. A clinician, not a reconstitution chart, is the right guide to any dose decision.